COMPARE · Data as of August 21, 2026

HNGE vs PRVA

Verdict: Side-by-side breakdown using the Bull Rankings model. HNGE scored 72.0, PRVA scored 56.3 — HNGE leads.
Compare another set
HNGE
Hinge Health, Inc.
Health Information Services · Quality-Growth
72
$88.42 · $7.1B
fundamentals as of
Score gap
15.7
HNGE leads
PRVA
Privia Health Group, Inc.
Health Information Services · Quality-Growth
56.3
$21.12 · $2.7B
fundamentals as of
  • CheapestHNGE10.8x
  • Fastest growthHNGE+49.8%
  • Strongest balance sheetPRVA0.01
  • Highest qualityHNGE97 / 100
  • Largest discount to fair valuePRVA-14%
THE BULL RANKINGS SCORECARD72.0/ 100 · BULL SCOREPEER MEDIANQUALITY96.5GROWTH66.3VALUE70.7
THE BULL RANKINGS SCORECARD56.3/ 100 · BULL SCOREPEER MEDIANQUALITY44.6GROWTH91.1VALUE44.0
HNGEPRVAQuality96.544.6Growth66.391.1Value70.744.0
cheap & fastrevenue growth →← cheaper (lower multiple)40%60%+5.8x16x+HNGEoff-scalePRVA

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFHNGE$290mPRVA$131m
RevHNGE+49.8%PRVA+24.1%
D/EHNGE0.02PRVA0.01
P/EHNGE10.8xPRVA96.0x
PEGHNGE0.36PRVA4.50
HNGE
stronger →← stronger
PRVA
97
Qualityreturns · margins · balance sheet
45
66
Growthrevenue & earnings expansion
91
71
Valuevaluation vs sector peers
44
HNGE is stronger on 2 of 3 pillars.
HNGE
PRVA
$290mC
FCF
$131mC
+49.8%A
Rev
+24.1%A-
0.02A-
D/E
0.01A
10.8xA
P/E
96.0xD
0.36A
PEG
4.50D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
HNGE
PRVA
5% above
Price vs fair valuelower is cheaper
14% below
~16%/yr
Growth the price implies10-yr FCF · lower = less priced in
~9%/yr
-27%
1-yr DCF upside
-8%
-5%
5-yr DCF upside
+16%
+43%
10-yr DCF upside
+63%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
HNGE
Why this score
  • Short track record
PRVA
Why this score
  • Diluting shareholders
HNGEHinge Health, Inc.
Health Information Services · $88.42
Why now
Health Information Services · market cap $7.1b. 5% off the 52-week high of $93.13. Revenue growing +50% — in hypergrowth territory. PEG 0.36 — paying under fair value for the growth rate. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $106.47 (implying +20% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 32% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
PRVAPrivia Health Group, Inc.
Health Information Services · $21.12 · beta 0.90
Why now
Health Information Services · market cap $2.7b. Down 27% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.67 (implying +50% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 96.0x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where HNGE and PRVA diverge

On the headline score the gap is 15.7 points in favor of HNGE. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.